Renal Cell Carcinoma Whole Blood
Whole blood from donors with confirmed renal cell carcinoma (RCC). Useful for VHL gene loss research and tyrosine kinase inhibitor response studies.
Renal Cell Carcinoma Whole Blood for Research
Renal cell carcinoma (RCC) is the most common form of kidney cancer, with the clear cell subtype frequently driven by VHL gene loss and studied through angiogenesis and immune checkpoint pathways. Sanguine collects fresh whole blood from IRB-consented donors with a clinically confirmed RCC diagnosis for oncology biomarker research.
Product Features
- Fresh whole blood from clinically diagnosed RCC donors
- Custom anticoagulants and collection tubes available
- Same-day collection and shipment
- Research Use Only (RUO)
De-identified Donor Data
- Physician-confirmed diagnosis, including RCC subtype and VHL status where available
- Demographics: age, sex assigned at birth, ethnicity
- Relevant medical and treatment history
Applications
- VHL gene loss and angiogenesis pathway research
- Immune checkpoint biomarker studies
- Gene expression and transcriptomic analysis
- Tyrosine kinase inhibitor and immunotherapy response research
Also Available
Looking for our general kidney cancer product? See our Kidney Cancer Whole Blood product.
Compliance and Quality
- IRB-approved protocols and electronic informed consent
- HIPAA-compliant donor data handling
Ordering and Customization
RCC whole blood is available in standard and custom volumes. Email learnmore@sanguinebio.com for international orders or documentation requirements.
Whole Blood
Frequently Asked Questions
1 Answer
YES – All collections are conducted under IRB-approved protocols and electronic informed consent. Sanguine utilizes Advarra and WCG IRB for oversight.
1 Answer
YES – all our products are research use only (RUO).
1 Answer
You can find our full product catalog here.
1 Answer
Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.
1 Answer
Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.
1 Answer
Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.
1 Answer
Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.
1 Answer
YES – we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.
1 Answer
Each sample from a different individual – Unique donor means each sample comes from a different person, ensuring biological diversity in your study.
1 Answer
YES – Unique donors can be specified and guaranteed based on your requirements.
1 Answer
For information about sample quality, please see: Quality and Compliance
1 Answer
YES – “IRB-approved collection protocols” and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.
Ask a Question
Need a custom Whole Blood cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.